Terminated PHASE3 INTERVENTIONAL 2-arm NCT02052440

Preventing Alcohol Withdrawal Syndrome With Oral Baclofen

Preventing Alcohol Withdrawal Syndrome With Oral Baclofen: A Randomized, Placebo Controlled Trial

Sponsor: Denver Health and Hospital Authority

Updated 8 times since 2017 Last updated: Apr 25, 2018 Started: Mar 15, 2014 Primary completion: Jan 1, 2017 Completion: Jan 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient funding to complete with low enrollment rate

Other terminated trials from Denver Health and Hospital Authority

See all terminations from Denver Health and Hospital Authority

Listed as NCT02052440, this PHASE3 trial focuses on Alcohol Withdrawal Syndrome and remains terminated or withdrawn. Sponsored by Denver Health and Hospital Authority, it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Terminated PHASE3
Aug 2017 — Apr 2018 [monthly]

Terminated PHASE3

Status: Recruiting → Terminated
Jan 2017 — Aug 2017 [monthly]

Recruiting PHASE3

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Denver Health and Hospital Authority

Data source: Denver Health and Hospital Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Denver, United States